Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms HRS 9815, HRS-9815, HRS9815 |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 1 | - | 01 Oct 2023 | |
PSMA-Positive Prostatic Cancer | IND Approval | CN | 07 Jul 2023 |